About My Health Careers Internship MedBlogs Contact us
Medindia
LOGIN REGISTER
Advertisement

Key to Improving Outcomes for Some Brain Cancers Discovered

by Colleen Fleiss on February 15, 2019 at 1:27 AM
Font : A-A+

Key to Improving Outcomes for Some Brain Cancers Discovered

IDH1 gene mutation seen in about half of all brain tumors produces a response that prevents radiation treatment from working, said researchers from the University of Michigan Rogel Cancer Center. Altering that response using FDA-approved drugs restores tumors' sensitivity to radiation therapy, extending survival in mice.

The paper, representing more than five years of research, is published in Science Translational Medicine.

Advertisement


"These findings have great potential to impact medical treatment of patients with low-grade glioma, which is critically needed for this terrible disease," says senior author Maria G. Castro, Ph.D., R. C. Schneider Collegiate Professor of Neurosurgery and a professor of cell and developmental biology at Michigan Medicine.

"The challenge is that following initial treatment with surgery and chemotherapy, the tumors always come back, and they come back with a vengeance," Castro says. "If we can intervene early in this diagnosis, before the tumor comes back more aggressive and deadly, it could have a big impact for these patients."
Advertisement

The researchers created a mouse model of IDH1-mutant glioma. The IDH1 mutation does not in itself cause cancer. For a tumor to form, mutations must occur in IDH1, p53 and ATRX.

The researchers discovered that when all three mutations are present, mutated IDH1 increases the tumor cells' DNA damage response. This reduces the efficacy of the radiation treatment, as the cancer cells can now correct the radiation-induced DNA damage.

Adding a drug that inhibits a critical pathway in DNA damage repair made the tumors sensitive to radiation treatment. Researchers initially discovered this using the newly created mutant IDH1 mouse models and confirmed their findings in tissue samples from patients with IDH1-mutant glioma. This suggests that a precision medicine approach to gliomas would better direct their treatment.

"Our findings elucidate how mutant IDH1 interferes with current glioma treatments and provides a blueprint on how to overcome such interference. As a direct consequence of these data, we will implement a series of novel clinical trials at our institution in the near future," says Pedro R. Lowenstein, M.D., Ph.D., Richard C. Schneider Collegiate Professor of Neurosurgery and professor of cell and developmental biology.

The FDA has already approved DNA repair blockers to enhance sensitivity to chemotherapy or radiation in some cancers. The researchers are currently working with colleagues in radiation oncology, pathology, neuro-oncology and neurosurgery to translate their findings into a clinical trial to test the combination in patients with low-grade gliomas with IDH1 mutation.

Pathologists already test for IDH1 mutation as part of the diagnostic process because it influences prognosis and treatment, so this therapeutic strategy would be straightforward to implement in clinic.

"Now we have a potential new way of treating these tumors, that will make radiation deliver a much bigger impact," says lead study author Felipe J. Nunez, Ph.D., a research specialist in the Castro/Lowenstein lab. "By combining these two approaches, we hope that the new treatment will extend remission in these patients and potentially turn low-grade glioma into a chronic disease."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Emotional Healing
Psychosis Risk Related to Cat Parasite
Sedentary Behavior Precipitates Night-Time Hot Flashes
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Parkinsons Disease Surgical Treatment Brain Brain Facts Ataxia Language Areas in The Brain Ways to Improve your Intelligence Quotient (IQ) Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors ....
Brain Tumor in Children
An abnormal growth of cells in the brain is called brain tumor. Most tumors arise within the brain ...
Quiz on Brain Tumor
Brain tumor is a group of cells with abnormal growth in the brain. A primary brain tumor indicates ....
Breakthrough in Drug Development & Personalized Medicine for Brain Tumor
New drugs could be developed for glioblastoma basing on Human induced pluripotent stem cell (IPSC) ....
Ataxia
Ataxia affects coordination. Gait becomes unstable and the patient loses balance. The cerebellum or ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Language Areas in The Brain
The mechanism of how human brain processes the language to express and comprehend the verbal, writte...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...
Parkinsons Disease
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. ...
Ways to Improve your Intelligence Quotient (IQ)
Intelligence quotient (IQ) is a psychological measure of human intelligence. Regular physical and me...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use